Role of Nuclear Factor (NF)-κB Activation in Tumor Growth and Metastasis

2003 ◽  
Vol 3 (1) ◽  
pp. 38
Author(s):  
Hyun-Mi Ko ◽  
Jung-Hwa Choi ◽  
Myung-Suk Ra ◽  
Suhn-Young Im
2018 ◽  
pp. 12-20
Author(s):  
S.P. Sviridova ◽  
Sh.R. Kashiya ◽  
O.A. Obukhova ◽  
M.V. Rubanskaya ◽  
A.V. Sotnikov

2015 ◽  
Vol 97 (5) ◽  
pp. 929-940 ◽  
Author(s):  
Stephania Libreros ◽  
Ramon Garcia-Areas ◽  
Patricia Keating ◽  
Nathalia Gazaniga ◽  
Philip Robinson ◽  
...  

2012 ◽  
Vol 72 (9) ◽  
pp. 2262-2274 ◽  
Author(s):  
Franco Capozza ◽  
Casey Trimmer ◽  
Remedios Castello-Cros ◽  
Sanjay Katiyar ◽  
Diana Whitaker-Menezes ◽  
...  

2021 ◽  
Vol 12 (10) ◽  
Author(s):  
Chunyu Zhang ◽  
Pan Liu ◽  
Jiaming Huang ◽  
Yuandong Liao ◽  
Chaoyun Pan ◽  
...  

AbstractCircular RNAs (circRNAs) are known to act as key regulators in a variety of malignancies. However, the role of circRNAs in cervical cancer (CCa) remains largely unknown. Herein, we demonstrated that a circRNA derived from the TADA2A gene (hsa_circ_0043280) was significantly downregulated in CCa and that this reduction in expression was correlated with a poor prognosis. Furthermore, our results demonstrated that hsa_circ_0043280 functions as a tumor suppressor to inhibit tumor growth and metastasis in CCa. Mechanistically, hsa_circ_0043280 competitively sponges miR-203a-3p and prevents miR-203a-3p from reducing the levels of PAQR3. Collectively, our results demonstrate that hsa_circ_0043280 plays a pivotal role in the development and metastasis of CCa, thus suggesting that hsa_circ_0043280 has significant potential as a prognostic biomarker and a therapeutic target for CCa.


2000 ◽  
pp. 201-217
Author(s):  
D. Nie ◽  
K. Tang ◽  
K. Szekeres ◽  
M. Trikha ◽  
K. V. Honn

2010 ◽  
Vol 138 (5) ◽  
pp. S-113
Author(s):  
Scott R. Silva ◽  
Kanika A. Bowen ◽  
Piotr G. Rychahou ◽  
Lindsey N. Jackson ◽  
Eun Y. Lee ◽  
...  

2018 ◽  
Vol 17 (4) ◽  
pp. 825-837 ◽  
Author(s):  
Sung Baek Jeong ◽  
Ji Hye Im ◽  
Jeong-Hoon Yoon ◽  
Quyen Thu Bui ◽  
Sung Chul Lim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document